ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Nozinan, solution injectable (i.m.) - 5 Ampulle(n)
24341046 Sanofi-Aventis (Suisse) SA
Nozinan, solution injectable (i.m.)22.08.1958
  22.08.1958
Levomepromazine (N05AA02)28.04.2006
WHO-DDD16.02.2019
01.05.5 Ampulle(n)
01.05. 
B  
No 
IPCI
PR  
k.A.PR
  
7680243410465Synthetika human
  
Composition
levomepromazinum 25 mg ut levomepromazini hydrochloridum, natrii chloridum, antiox.: E 221 500 µg, E 300 1 mg, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution
 
Active AgentDose
Levomepromazine25 mg/ml correspond Levomepromazine Hydrochloride
Source
Data was imported : 04.12.2014 Swissmedic Registration : 24341 Sequence : 01 Product name : Nozinan, solution injectable (i.m.) Registration owner: : Sanofi-Aventis (Suisse) SA Product group : Index Therapeuticus (BSV) : 01.05.0. Medication Code : Synthetika human Date of registration : 22.08.1958 Valid until : 16.02.2019 Package number : 046 Show package size : 5 Commercial Form/Unit : Ampulle(n) Swissmedic categorie. : B Active Agents : levomepromazinum Composition : levomepromazinum 25 mg ut levomepromazini hydrochloridum, natrii chloridum, antiox.: E 221 500 µg, E 300 1 mg, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home